Literature DB >> 29526448

S. aureus endocarditis: Clinical aspects and experimental approaches.

V Hoerr1, M Franz2, M W Pletz3, M Diab4, S Niemann5, C Faber6, T Doenst4, P C Schulze2, S Deinhardt-Emmer7, B Löffler7.   

Abstract

Infective endocarditis (IE) is a life-threatening disease, caused by septic vegetations and inflammatory foci on the surface of the endothelium and the valves. Due to its complex and often indecisive presentation the mortality rate is still about 30%. Most frequently bacterial microorganisms entering the bloodstream are the underlying origin of the intracardiac infection. While the disease was primarily restricted to younger patients suffering from rheumatic heart streptococci infections, new at risk categories for Staphylococcus (S.) aureus infections arose over the last years. Rising patient age, increasing drug resistance, intensive treatment conditions such as renal hemodialysis, immunosuppression and long term indwelling central venous catheters but also the application of modern cardiac device implants and valve prosthesis have led to emerging incidences of S. aureus IE in health care settings and community. The aetiologic change has impact on the pathophysiology of IE, the clinical presentation and the overall patient management. Despite intensive research on appropriate in vitro and in vivo models of IE and gained knowledge about the fundamental mechanisms in the formation of bacterial vegetations and extracardiac complications, improved understanding of relevant bacterial virulence factors and triggered host immune responses is required to help developing novel antipathogenic treatment strategies and pathogen specific diagnostic markers. In this review, we summarize and discuss the two main areas affected by the changing patient demographics and provide first, recent knowledge about the pathogenic strategies of S. aureus in the induction of IE, including available experimental models of IE used to study host-pathogen interactions and diagnostic and therapeutic targets. In a second focus we present diagnostic (imaging) regimens for patients with S. aureus IE according to current guidelines as well as treatment strategies and surgical recommendations.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Clinical management; Diagnostic regimens; Experimental models; Pathophysiological mechanisms; S. aureus infective endocarditis; Therapeutic treatment and surgical intervention

Mesh:

Year:  2018        PMID: 29526448     DOI: 10.1016/j.ijmm.2018.02.004

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  8 in total

Review 1.  Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms.

Authors:  Jakub M Kwiecinski; Alexander R Horswill
Journal:  Curr Opin Microbiol       Date:  2020-03-12       Impact factor: 7.934

Review 2.  Fighting Staphylococcus aureus Biofilms with Monoclonal Antibodies.

Authors:  Dina Raafat; Michael Otto; Kevin Reppschläger; Jawad Iqbal; Silva Holtfreter
Journal:  Trends Microbiol       Date:  2019-01-19       Impact factor: 17.079

3.  Infective Endocarditis: Preliminary Results of a Cohort Study in the Southern Italian Population.

Authors:  Nicola Serra; Claudia Colomba; Paola Di Carlo; Gabriele Palermo; Teresa Fasciana; Anna Giammanco; Giuseppina Novo; Teresa Rea; Maria Michela Marino; Vincenzo Argano; Consolato Sergi
Journal:  Cureus       Date:  2020-05-28

4.  Structure, Mechanical, and Lytic Stability of Fibrin and Plasma Coagulum Generated by Staphylocoagulase From Staphylococcus aureus.

Authors:  Ádám Z Farkas; Veronika J Farkas; László Szabó; András Wacha; Attila Bóta; Lóránt Csehi; Krasimir Kolev; Craig Thelwell
Journal:  Front Immunol       Date:  2019-12-20       Impact factor: 7.561

5.  Host-pathogen interactions of clinical S. aureus isolates to induce infective endocarditis.

Authors:  Christian Schwarz; Yasemin Töre; Vanessa Hoesker; Sabine Ameling; Katja Grün; Uwe Völker; P Christian Schulze; Marcus Franz; Cornelius Faber; Frieder Schaumburg; Silke Niemann; Verena Hoerr
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 6.  Clinical Features and Comparison of Kingella and Non-Kingella Endocarditis in Children, Israel.

Authors:  Alexander Lowenthal; Hila Weisblum-Neuman; Einat Birk; Liat Ashkenazi-Hoffnung; Itzhak Levy; Haim Ben-Zvi; Gabriel Amir; Georgy Frenkel; Elchanan Bruckheimer; Havatzelet Yarden-Bilavsky; Dafna Marom; Eran Shostak; Elhanan Nahum; Tamir Dagan; Gabriel Chodick; Oded Scheuerman
Journal:  Emerg Infect Dis       Date:  2021-03       Impact factor: 16.126

Review 7.  Staphylococcus aureus-A Known Opponent against Host Defense Mechanisms and Vaccine Development-Do We Still Have a Chance to Win?

Authors:  Urszula Wójcik-Bojek; Barbara Różalska; Beata Sadowska
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923

8.  Characteristics of infective endocarditis in a cancer population.

Authors:  Cullen Grable; Syed W Yusuf; Juhee Song; George M Viola; Owais Ulhaq; Jose Banchs; Corey T Jensen; Harsh Goel; Saamir A Hassan
Journal:  Open Heart       Date:  2021-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.